Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abiomed Inc (NQ: ABMD ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Dec 21, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Abiomed Inc < Previous 1 2 3 4 5 Next > Risk Vs Reward Vs Folly: Navigating Investment Choices September 29, 2023 During the dot-com era, many individuals ridiculed Buffett for his refusal to invest in ventures that contradicted his principles. Years later, the majority of these so-called experts, if not all of... Via Talk Markets Is It Too Late to Buy Johnson & Johnson's Stock? April 28, 2023 This healthcare juggernaut's recent quarterly results prove just how strong its business is. Via The Motley Fool 2 Best Buffett Stocks to Buy for the Long Haul December 27, 2022 Both of these stocks look like bargains right now. Via The Motley Fool FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial December 21, 2022 From Abiomed, Inc. Via Business Wire If You Invested $100 In This Stock 10 Years Ago, You Would Have $2,800 Today December 08, 2022 Via Benzinga Here's How Much You Would Have Made Owning Abiomed Stock In The Last 15 Years November 21, 2022 Via Benzinga Will Investors Notice Exciting Sign On Abiomed's Chart? November 16, 2022 Via Benzinga Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks December 21, 2022 Even if interest rates go up, you likely won't need to worry about these stocks. Via The Motley Fool The Best Stocks to Invest $20,000 in Right Now December 21, 2022 The investments you make now could power your portfolio returns for years to come. Via The Motley Fool Warren Buffett Loves These Stocks. Should You Buy Them Before 2023? December 16, 2022 There's a lot more ahead for these market giants. Via The Motley Fool Pfizer, Novartis Are Among Overbought Healthcare Stocks: Are They Worth A Look? December 14, 2022 The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies. Here’s the latest list of major overbought players in this sector, with an RSI... Via Benzinga 2 Top Dividend Kings to Buy for the Long Haul December 14, 2022 No matter how much changes, these two healthcare giants keep performing. Via The Motley Fool Can Pfizer, Johnson & Johnson Continue Outperforming the Index? December 09, 2022 Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months. Via MarketBeat This Monster Dividend Stock Isn't Done Growing December 08, 2022 Is another deal on the way for Johnson & Johnson? Via The Motley Fool Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi December 05, 2022 There are now two companies in the ring for a Horizon takeover. Via Investor's Business Daily First Patients in the World Treated with Impella RP Flex with SmartAssist December 05, 2022 From Abiomed, Inc. Via Business Wire 3 Healthcare Stocks to Buy and Hold for the Next 10 Years December 02, 2022 This space is ripe with opportunities for investors. Via The Motley Fool Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout November 30, 2022 Via Benzinga Bear Market Blues? 3 of the Best Stocks to Own in 2023 November 19, 2022 2023 could be a big year for each of these healthcare companies. Via The Motley Fool Peering Into Abiomed's Recent Short Interest November 17, 2022 Abiomed's (NASDAQ:ABMD) short percent of float has risen 6.62% since its last report. The company recently reported that it has 2.08 million shares sold short, which is 5.96% of all regular shares that... Via Benzinga ABIOMED INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abiomed, Inc. - ABMD November 16, 2022 From Kahn Swick & Foti, LLC Via Business Wire S&P 500 Component DexCom Set For Further Price, Earnings Growth November 13, 2022 Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023. Via MarketBeat Topics Stocks Exposures US Equities 2 Warren Buffett Passive Income Stocks You Can Buy to Boost Your Yield November 11, 2022 Buffett loves stocks that pay dividends. Is it any wonder Berkshire Hathaway is poised to collect more than $6 billion worth of them next year? Via The Motley Fool Better Buy: Johnson & Johnson vs. Abbott Laboratories November 10, 2022 These two healthcare giants are among the safest stocks investors can buy right now. Via The Motley Fool Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed November 10, 2022 The company is planting seeds for future growth. Via The Motley Fool BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Oyster Point Pharma, Inc. (Nasdaq - OYST), Benefitfocus, Inc. (Nasdaq - BNFT), Abiomed, Inc. (Nasdaq - ABMD), Atlas Corp. (NYSE - ATCO) November 08, 2022 From Brodsky & Smith LLC Via GlobeNewswire 2 Healthcare Stocks You Can Buy and Hold for the Next Decade November 08, 2022 These robust businesses will be around well beyond the next 10 years. Via The Motley Fool 3 No-Brainer Stocks to Buy in a Downturn November 08, 2022 These companies thrive when others falter. Via The Motley Fool Johnson & Johnson's Big Purchase, Amazon's New Moves, and More November 05, 2022 Plus, we run through some shortcuts that could help you with your financial planning. Via The Motley Fool Is Johnson & Johnson's Purchase of Abiomed Good for Investors? November 05, 2022 The $16.6 billion acquisition shakes up MedTech. Via The Motley Fool < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.